AN OBSERVATORY FOR PATIENTS AGED 18 YEARS AND OVER WITH PHILADELPHIA CHROMOSOME POSITIVE (PH+ OR BCR::ABL1+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND TREATED WITH THE COMBINATION OF BCR::ABL1 INHIBITORS AND CHEMOTHERAPY AND/OR CORTICOSTEROIDS AND/OR A MONOCLONAL ANTIBODY.
Status: Recruiting
Location: See all (23) locations...
Study Type: Observational
SUMMARY
An observatory for patients aged 18 years and over with Philadelphia chromosome positive (Ph+ or BCR::ABL1) acute lymphoblastic leukemia (ALL) and treated with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticosteroids and/or a monoclonal antibody.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Male or female patients ≥ 18 years
• Philadelphia chromosome or BCR::ABL1 positive acute lymphoblastic leukaemia
• Treatment with the combination of BCR::ABL1 inhibitors and chemotherapy and/or corticotherapy and/or a monoclonal antibody
Locations
Other Locations
France
Groupe hospitalier sud
NOT_YET_RECRUITING
Amiens
CHU Angers
NOT_YET_RECRUITING
Angers
CH de la cote basque
NOT_YET_RECRUITING
Bayonne
CHU Bordeaux
RECRUITING
Bordeaux
Hopital Militaire Percy
NOT_YET_RECRUITING
Clamart
CHU clermont ferrand
RECRUITING
Clermont-ferrand
Centre Hospitalier sud francilien
RECRUITING
Corbeil-essonnes
CHU de grenoble
NOT_YET_RECRUITING
Grenoble
CHU Sud Réunion
NOT_YET_RECRUITING
La Réunion
CH Versailles
RECRUITING
Le Chesnay
CH Le Mans
RECRUITING
Le Mans
Chu de Lille
NOT_YET_RECRUITING
Lille
Hopital de la conception
NOT_YET_RECRUITING
Marseille
Institut Paoli Calmettes
NOT_YET_RECRUITING
Marseille
CHRU de Nancy
NOT_YET_RECRUITING
Nancy
Centre Antoine Lacassagne
NOT_YET_RECRUITING
Nice
Hopital Cochin
NOT_YET_RECRUITING
Paris
Hopital necker
RECRUITING
Paris
Hopital St Louis
RECRUITING
Paris
CH de Lyon
NOT_YET_RECRUITING
Pierre-bénite
CH St Etienne
NOT_YET_RECRUITING
Saint-etienne
ICANS
NOT_YET_RECRUITING
Strasbourg
Hopital de Purpan
NOT_YET_RECRUITING
Toulouse
Contact Information
Primary
Sandrine Roux
sroux@ght78sud.fr
+33139239777
Time Frame
Start Date: 2024-01-15
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 100
Related Therapeutic Areas
Sponsors
Leads: Versailles Hospital